Longidaza®
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
NPO Petrovax
Overview
Longidaza® is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Longidaza® clinical trials
Explore related
Medical disclaimer. This page summarizes research about Longidaza® for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.